A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma

Clinical trial NCT00592579 · COMPLETED

Trial details

NCT number: NCT00592579
Sponsor: CASI pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Multiple Myeloma Plateau Phase Multiple Myeloma

Start date: 2001-03-01
Primary completion: 2008-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.